Cargando…
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis
Increased myeloperoxidase (MPO) expression and activity are associated with atherosclerotic disease in patients with chronic kidney disease (CKD). However, the causal relationship between MPO and the development and progression of atherosclerosis in patients with CKD is unknown. Eight-week-old male...
Autores principales: | Mathew, Anna V., Zeng, Lixia, Atkins, Kevin B., Sadri, Kiana N., Byun, Jaeman, Fujiwara, Hideaki, Reddy, Pavan, Pennathur, Subramaniam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948401/ https://www.ncbi.nlm.nih.gov/pubmed/33234591 http://dx.doi.org/10.1074/jbc.RA120.014095 |
Ejemplares similares
-
Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis
por: Mathew, Anna V, et al.
Publicado: (2015) -
Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
por: Mathew, Anna V., et al.
Publicado: (2018) -
Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018) -
Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
por: Mathew, Anna V., et al.
Publicado: (2019) -
Role of myeloperoxidase in inflammation and atherosclerosis (Review)
por: Frangie, Christian, et al.
Publicado: (2022)